Theriva Biologics, Inc. Stock Split Ratio
Theriva Biologics, Inc. (TOVX) had Stock Split Ratio of 4.00% as of 2024-08-26, per its 10-K filed 2026-03-12.
Financial Statements › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2026-03-12
- 2024-08-26: Stockholders' Equity Note, Stock Split, Conversion Ratio 4.00%.
- 2022-07-25: Stockholders' Equity Note, Stock Split, Conversion Ratio 100.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 10.00%.
- 2022-07-11: Stockholders' Equity Note, Stock Split, Conversion Ratio 1000.00%; Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed 10.00%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio | Stockholders' Equity Note, Stock Split, Conversion Ratio as first filed |
|---|---|---|
| 2024-08-26 | 4.00% 10-K · filed 2026-03-12 | |
| 2022-07-25 | 100.00% 10-K · filed 2024-03-25 | 10.00% 10-Q · filed 2022-08-11 |
| 2022-07-11 | 1000.00% 10-K · filed 2024-03-25 | 10.00% 10-Q · filed 2022-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |